News Scope Fluidics S.A.

Stocks

SCP

PLSCPFL00018

Biotechnology & Medical Research

Delayed Warsaw S.E. Other stock markets 07:18:02 24/07/2026 pm IST			5-day change	1st Jan Change
118.40 ^PLN	-0.50%		-1.33%	-13.07%

27/05	Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip'	RE
15/05	Scope Fluidics Q1 net loss at 13.5 million zlotys	RE

All News

Mentions Relevance

27/05	Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip'	RE
15/05	Scope Fluidics Q1 net loss at 13.5 million zlotys	RE
15/05	Scope Fluidics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
21/04	Scope Fluidics unit Bacteromic starts collaboration with US research center for FDA registration trials	RE
25/03	Scope Fluidics FY net loss at 46.4 million zlotys	RE
25/03	Scope Fluidics S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
09/03	Scope Fluidics updates objectives for Bacteromic project for 2026-2027	RE
20/02	Scope Fluidics obtains CE-IVDR certification for Bacteromic System	RE
12/02	Scope Fluidics unit adopts plan for production readiness for Bacteromic system panels	RE
21/01	Scope Fluidics unit signs framework distribution deal with SC Elta 90 Medical Research	RE
08/01	Scope Fluidics signs distribution deal for Bacteromic system in Turkey	RE
23/12	Scope Fluidics says unit Bacteromic ends cooperation with MicroLiquid	RE
12/12	Scope Fluidics says unit receives conditional grant approval for Hybolic project	RE
02/12	Scope Fluidics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
01/12	Scope Fluidics Q3 net loss at 11.4 million zlotys	RE
03/11	Scope Fluidics says shareholder sells stake in company	RE
29/25/29	Scope Fluidics says shareholders complete ABB process for 16% of stake	RE
27/25/27	Scope Fluidics starts ABB process	RE
27/25/27	Scope Fluidics to raise share capital via issue of up to 0.4 million new shares	RE
26/25/26	Scope Fluidics extends collaboration for FDA certification	RE
20/25/20	Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
19/25/19	Scope Fluidics Q2 net loss at 8.6 mln zlotys	RE
16/25/16	Scope Fluidics approves timeline change for Hybolic project goal	RE
15/25/15	Scope Fluidics board okays EIB financing pursuit for Bacteromic	RE
06/25/06	Scope Fluidics informs about achieving first goal in Edocera project	RE